11β-Hydroxysteroid dehydrogenase deficit: A rare cause of arterial hypertension. Diagnosis and therapeutic approach in two young brothers

European Journal of Endocrinology

Volumn 135, Issue 2, 1996, Pages 238-244

  Gourmelen, Micheline ^a   Saint Jacques, Irène ^b   Morineau, Gilles ^c   Soliman, Hany ^c   Julien, René ^c   Fiet, Jean ^c  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b Service Pédiatrique   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DEXAMETHASONE; SPIRONOLACTONE; TETRACOSACTIDE; TETRAHYDROCORTICOSTERONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; ENZYME DEFICIENCY; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL;

EID: 0029790677     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350238     Document Type: Article

References (50)

1. New MI, Levine LS, Biglieri EG, Pariera J, Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol 1977;44:924-33
2. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757-64
3. Sheppard KE, Funder HJW. Equivalent affinity of aldosterone and corticosterone for type I receptor in kidney and hippocampus direct binding studies. J Steroid Biochem 1987;28:737-42
4. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin B, Housman DE, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kindship with the glucocorticoid receptor. Science 1987;237:268-75
5. Monder C, Shakleton CHL, Bradlow HL, New MI, Stoner E, Iohan F, et al. The syndrome of apparent mineralocorticoid excess: its association with 11β-dehydrogenase and 5β-reductase deficiency and some consequences for corticosteroid metabolism. J Clin Endocrinol Metab 1986;63:550-7
6. Pham-Huu-Trung MT, Corvol P. A direct determination of plasma aldosterone. Steroid 1974;24:587-98
7. Fiet J, Gosling JP, Soliman H, Galons H, Boudou Ph, Aubin Ph, et al. Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroid. Clin Chem 1994;40:2296-305
8. Proeschel MF, Courvalin JC, Donnadieu M, Binoux M, Girard F. Preparation and evaluation of ACTH antibodies. Acta Endocrinol (Copenh) 1974;75:461-77
9. Haber E, Koerner T, Page LB. Application of a radioimmunoassay for angiotensin 1 to the physiologic measurements of plasma renin activity in normal subjects. J Clin Endocrinol 1969;19: 1349-55
10. Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, Van de Calseyde JF, Wolthers AJ. Steroid profile for urine. Reference values. Clin Chem 1989;35:2281-4
11. Chambaz EM, Horning EC. Conversion of steroids to trimethyl derivatives for gas phase analytical studies: reactions of silytating reagents Anal Biochem 1969;30:7-24
12. Chebroux P, Rigaud M, Soustre A, Breton JC. Determination par Chromatographie gaz-liquide sur colonnes capillaires en verre å haute performance des stéroides urinaires. In: Lavoué G, editor. Les nouvelles dimensions de la Chromatographie en phase gazeuse. Lab. France Paris, 1982
13. New MI, Bradlow P, Fishman J, Gunczler P, Zaconato G, Rauh W. et al. Deficiency of Cortisol 11β-ketoreductase. A new metabolic defect [abstract] Pediatr Res 1978;12:416
14. Bonvalet JP, Doignon I, Blot-Chabaud M, Pradelles P, Farman N. Distribution of 11β-hydroxysteroid dehydrogenase along the rabbit nephron. J Clin Invest 1990;86:832-7
15. Ulick S, Tedde R, Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1992;74:593-9
16. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isoenzyme of 11β-hydroxysteroid dehydrogenase. Nature Genet 1995;10: 394-9
17. Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, et al. Defects in the HSD gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Metab 1993;77:687-91
18. Stewart PM, Murry BA, Mason JI. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 1994;79:480-4
19. Krozowski Z, Baker E, Obeyesekere V, Callen DF. Localisation of the gene for human 11β hydroxysteroid dehydrogenase type 2 (HSD11β2) to chromosome band 16q22. Cytogenet Cell Genet 1995;71:124-5
20. Agarwal AK, Rogerson FM, Mune T, White PC. Analysis of the human gene encoding the kidney isoenzyme of 11β hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 1995;55:473-9
21. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995;80:2263-6
22. Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CHL, Hanauske-Abel HM, et al. Several homozygous mutations in the gene for 11β hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995;80:3145-50
23. Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI. The R337C mutation generates a high Km 11β hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995;80: 3381-3
24. Ulick S, Ramirez LC, New MI. An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab 1977;44:799-802
25. Ulick S, Tedde R, Mantero F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1990;70:200-6
26. New Mi. Apparent mineralocorticoid excess: a personal history. Steroids 1994;59:66-8
27. Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1983;56:332-9
28. Speiser PW, Riddick LM, Martin K, New MI. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metabolism 1993;42:843-5
29. Winter JSD. A syndrome of low-renin hypertension in children. In: New MI, Levine LS, editors. Juvenile hypertension. 1977; 123-33
30. Shackleton CHL, Rodriguez J, Arteaga E, Lopez JM, Winter JSD. Congenital 11β hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolites profiles of four patients and their families. Clin Endocrinol 1985;22:701-12
31. Milford DV, Shackeleton CHL, Stewart PM. Mineralocorticoid hypertension and congenital deficiency of 11β hydroxysteroid dehydrogenase in a family with the syndrome of "apparent" mineralocorticoid excess. Clin Endocrinol 1994;43:241-6
32. Werder E, Zachmann M, Völlmin JA, Veyrat R, Prader A. Unusual steroid excretion in a child with low renin hypertension. In: Breuer H, editor. Transactions of the 6th meeting of international study for steroid hormones, Res Steroids 1974;6:385-9
33. Edwards CRW, Stewart PM, Nalrn IM, Grieve J, Shackleton CHL. Cushing's disease of the kidney. J Endocrinol 1985;104S:53
34. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. Syndrome of apparent mineralocorticoid excess. J Clin Invest 1988;82:340-9
35. Stewart PM, Whorwood CB, Walker BR. Steroid hormones and hypertension: the cortisol-cortisone shuttle. Steroids 1993; 58:614-20
36. Shackleton CHL, Honour JW, Dillon MJ, Chantler C, Jones RWA. J Clin Endocrinol Metab 1980;50:786-92
37. Fiselier TJW, Otten BJ, Monnens LAH, Honour JW, Van Munster PJJ. Horm Res 1982;16:107-14
38. Honour JW, Dillon MJ, Levin M, Shah V. Fatal, low-renin hypertension associated with a disturbance of cortisol metabolism. Arch Dis Child 1983;58:1018-20
39. Harinck HIJ, Van Brummelen P, Van Seters AP, Moolenaar AJ. Apparent mineralocorticoid excess and deficient 11β oxidation of cortisol in a young female. Clin Endocrinol 1984;21:505-14
40. Dimartino-Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI. New findings in apparent mineralocorticoid excess. Clin Endocrinol 1987;27:49-62
41. Batista MC, Mendonça BB, Kater CE, Arnhold IJP, Rocha A, Nicolau W, et al. Spironolactone-reversible rickets associated with 11β hydroxysteroid dehydrogenase deficiency syndrome. J Pediatr 1986;109:989-93
42. Sann L, Revol A, Sachmann M, Legrand JC, Bethenod M. Unusual low plasma renin hypertension in a child. J Clin Endocrinol Metab 1975;43:265-71
43. Kitanaka S, Tanae A, Hibi I. Apparent mineralocorticoid excess due to 11β hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin Endocrinol 1996;44:353-9
44. Igarashi Y, Egi S, Takehiro A, Ohzeki T, Kawaguchi H. Studies on the metabolic abnormality of cortisol and corticosterone in a case of dexamethasone responsive mineralocorticoid excess. Folia Endocrinol Jpn 1979;55:1341-57 (in Japanese)
45. Gourmelen M, Saint-Jacques I, Julien R. Déficit en 11β hydroxysteroide deshydrogénase à l'origine d'une HTA sévère chez 2 frères [abstract]. Ann Endocrinol Suppl 1993;144:123
46. Stewart PM, Edwards CRW. The cortisol-cortisone shuttle and hypertension. J Steroid Biochem Metab Biol 1991;40:501-9
47. Shackleton CHL, Stewart PM. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri EG, Melby JC, editors. Endocrine hypertension. 1990;155-73
48. Mantero F, Tedde R, Opocher G, Fulgheri PD, Arnaldi G, Ulick S. Apparent mineralocorticoid excess type II. Steroids 1994;59:80-3
49. Tedde R, Pala A, Melis A, Ulick S. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. J Endorcrinol Invest 1992;15:471-4
50. Ulick S, Chan CK, Rao N, Edassery J, Mantero F. A new form of the syndrome of apparent mineralocorticoid excess. J Steroid Biochem 1989;32:209-12